Direxion Daily S&P Biotech Bull 3X ETF(LABU · ETF)
ETF quote, holdings, sector allocation, technicals, and options analytics.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
Snapshot
$179.28
- 52-Week Range
- $53.14 – $212.45
- YTD
- +13.83%
- IV Rank (30D)
- 15.95
- Straddle Price
- $35.65
- P/C Vol Ratio
- 1.79
Info
Direxion Daily S&P Biotech Bull 3X ETF (LABU) ETF
- Exchange
- ARCX
- Inception
- 2015-05-28
- Has Options
- Yes
ETF Profile
holdings as of 2026-06-12
Holdings
158
AUM
$1.7B
Provider
Direxion
Inception
2015-05-28
Exchange
ARCX
Data As Of
2026-06-12
Expense Ratio
—
Dividend Yield
0.69%
Distribution
Quarterly
Recent distributions
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| 2025-12-23 | 2025-12-31 | $0.9097 | CD |
| 2025-09-23 | 2025-09-30 | $0.1027 | CD |
| 2025-06-24 | 2025-07-01 | $0.2190 | CD |
| 2025-03-25 | 2025-04-01 | $0.1071 | CD |
| 2024-06-25 | 2024-07-02 | $0.1502 | CD |
| 2024-03-19 | 2024-03-26 | $0.1606 | CD |
Asset Allocation
Top Holdings
top 50 of 158 holdings
| Symbol | Name | Weight % | Asset Class | Country |
|---|---|---|---|---|
| — | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 72.45% | Derivative | — |
| — | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 50.59% | Derivative | — |
| — | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 46.07% | Derivative | — |
| — | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 31.01% | Derivative | — |
| — | DREYFUS GOVT CASH MAN INS | 17.82% | Derivative | — |
| — | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 17.63% | Derivative | — |
| — | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 11.82% | Derivative | — |
| — | GOLDMAN FINL SQ TRSRY INST 506 | 7.78% | Derivative | — |
| — | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 4.19% | Derivative | — |
| — | GOLDMAN SACHS FIN GOV 465 INSTITUT | 2.83% | Derivative | — |
| TGTX | TG THERAPEUTICS INC | 1.32% | Equity (US) | — |
| TVTX | TRAVERE THERAPEUTICS INC | 1.28% | Equity (US) | — |
| ALKS | ALKERMES PLC | 1.25% | Equity (US) | — |
| TWST | TWIST BIOSCIENCE CORP | 1.22% | Equity (US) | — |
| RVMD | REVOLUTION MEDICINES INC | 1.16% | Equity (US) | — |
| EXEL | EXELIXIS INC | 0.99% | Equity (US) | — |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 0.99% | Equity (US) | — |
| KRYS | KRYSTAL BIOTECH INC | 0.97% | Equity (US) | — |
| NBIX | NEUROCRINE BIOSCIENCES INC | 0.97% | Equity (US) | — |
| NUVL | NUVALENT INC-A | 0.95% | Equity (US) | — |
| APGE | APOGEE THERAPEUTICS INC | 0.92% | Equity (US) | — |
| INCY | INCYTE CORP | 0.88% | Equity (US) | — |
| PTGX | PROTAGONIST THERAPEUTICS INC | 0.88% | Equity (US) | — |
| PTCT | PTC THERAPEUTICS INC | 0.88% | Equity (US) | — |
| BEAM | BEAM THERAPEUTICS INC | 0.87% | Equity (US) | — |
| NTRA | NATERA INC | 0.86% | Equity (US) | — |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 0.85% | Equity (US) | — |
| VCYT | VERACYTE INC | 0.85% | Equity (US) | — |
| CYTK | CYTOKINETICS INC | 0.84% | Equity (US) | — |
| MIRM | MIRUM PHARMACEUTICALS INC | 0.84% | Equity (US) | — |
| HALO | HALOZYME THERAPEUTICS INC | 0.82% | Equity (US) | — |
| BIIB | BIOGEN INC | 0.81% | Equity (US) | — |
| SRRK | SCHOLAR ROCK HOLDING CORP | 0.80% | Equity (US) | — |
| SYRE | SPYRE THERAPEUTICS INC | 0.79% | Equity (US) | — |
| KYMR | KYMERA THERAPEUTICS INC | 0.79% | Equity (US) | — |
| CRSP | CRISPR THERAPEUTICS AG | 0.78% | Equity (US) | — |
| ROIV | ROIVANT SCIENCES LTD | 0.78% | Equity (US) | — |
| UTHR | UNITED THERAPEUTICS CORP | 0.77% | Equity (US) | — |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 0.77% | Equity (US) | — |
| IMVT | IMMUNOVANT INC | 0.77% | Equity (US) | — |
| ABBV | ABBVIE INC | 0.76% | Equity (US) | — |
| IONS | IONIS PHARMACEUTICALS INC | 0.76% | Equity (US) | — |
| RYTM | RHYTHM PHARMACEUTICALS INC | 0.75% | Equity (US) | — |
| BBIO | BRIDGEBIO PHARMA INC | 0.73% | Equity (US) | — |
| AMGN | AMGEN INC | 0.72% | Equity (US) | — |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 0.71% | Equity (US) | — |
| COGT | COGENT BIOSCIENCES INC | 0.70% | Equity (US) | — |
| VRTX | VERTEX PHARMACEUTICALS INC | 0.70% | Equity (US) | — |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 0.70% | Equity (US) | — |
| MRNA | MODERNA INC | 0.68% | Equity (US) | — |
Geographic Breakdown
Fund Holdings
Direxion Daily S&P Biotech Bull 3X Shares ·
NPORT-P period 2026-10-31
(filed 2026-04-01)
Net assets:
$576M
· 161 total positions
· equity 54.78%
· non-equity 52.78%
| # | Symbol | Issuer | Weight | Value |
|---|---|---|---|---|
| 1 | Moderna Inc COM USD0.0001 | Moderna Inc | 1.02% | $5.9M |
| 2 | Mirum Pharmaceuticals Inc. COM USD0.0001 | Mirum Pharmaceuticals Inc. | 0.87% | $5.0M |
| 3 | Revolution Medicines Inc COM | Revolution Medicines Inc | 0.83% | $4.8M |
| 4 | Vaxcyte Inc COM | Vaxcyte Inc | 0.82% | $4.8M |
| 5 | Amicus Therapeutics Inc. COM STK USD0.01 | Amicus Therapeutics Inc. | 0.81% | $4.7M |
| 6 | PRAXIS PRECISION MEDICINES I | Praxis Precision Medicines Inc | 0.80% | $4.6M |
| 7 | Alkermes PLC COM USD0.01 | Alkermes PLC | 0.79% | $4.6M |
| 8 | Gilead Sciences, Inc. COM USD0.001 | Gilead Sciences Inc. | 0.78% | $4.5M |
| 9 | Krystal Biotech Inc COM USD0.00001 | Krystal Biotech Inc | 0.78% | $4.5M |
| 10 | Halozyme Therapeutics Inc COM USD0.001 | Halozyme Therapeutics Inc | 0.77% | $4.4M |
| 11 | Amgen Inc. COM USD0.0001 | Amgen Inc. | 0.73% | $4.2M |
| 12 | CELCUITY INC | Celcuity Inc. | 0.72% | $4.1M |
| 13 | ROIVANT SCIENCES LTD | Roivant Sciences Ltd | 0.72% | $4.1M |
| 14 | Bridgebio Pharma Inc COM USD0.001 | Bridgebio Pharma Inc | 0.71% | $4.1M |
| 15 | Vertex Pharmaceuticals Incorporated COM USD0.01 | Vertex Pharmaceuticals Incorporated | 0.71% | $4.1M |
| 16 | Biomarin Pharmaceutical Inc. COM USD0.001 | Biomarin Pharmaceutical Inc. | 0.71% | $4.1M |
| 17 | Incyte Corporation. COM USD0.001 | Incyte Corporation. | 0.70% | $4.1M |
| 18 | Ionis Pharmaceuticals, Inc. COM USD0.001 | Ionis Pharmaceuticals, Inc. | 0.70% | $4.1M |
| 19 | Cytokinetics Inc COM USD0.001 | Cytokinetics Inc | 0.70% | $4.0M |
| 20 | GRAIL INC | GRAIL Inc | 0.69% | $4.0M |
| 21 | Regeneron Pharmaceuticals, Inc. COM USD0.001 | Regeneron Pharmaceuticals, Inc. | 0.68% | $3.9M |
| 22 | PTC Therapeutics, Inc. COM USD0.001 | PTC Therapeutics, Inc. | 0.68% | $3.9M |
| 23 | Avidity Biosciences Inc. COM | Avidity Biosciences Inc. | 0.68% | $3.9M |
| 24 | Biogen Inc COM USD0.0005 | Biogen Inc | 0.68% | $3.9M |
| 25 | Exact Sciences Corporation COM USD0.01 | Exact Sciences Corporation | 0.68% | $3.9M |
Showing top 25 of 150 equity holdings.
Non-equity holdings
— 11 positions,
52.78% of NAV
| Category | Weight | Value | Positions |
|---|---|---|---|
| Short-term investment | 50.69% | $292.2M | 4 |
| Derivative (equity) | 2.09% | $12.0M | 7 |
Daily issuer data also available
(2026-06-13)
via ETF Constituents
Price History
Seasonality
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +1.86% | 11 |
| Feb | -1.25% | 11 |
| Mar | -14.57% | 11 |
| Apr | +1.07% | 11 |
| May | +2.10% | 12 |
| Jun | +9.58% | 12 |
| Jul | +5.07% | 11 |
| Aug | -0.66% | 11 |
| Sep | -6.24% | 11 |
| Oct | -5.59% | 11 |
| Nov | +18.68% | 11 |
| Dec | -4.28% | 11 |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $173.09
SMA 50: $181.67
SMA 200: $149.95
Current: $178.62
EMA 12: $172.09
EMA 26: $175.15
MACD: -3.0523 | Signal: -0.0764
BEARISH
ADX (14): 8.59
RANGE
+DI: 24.79
−DI: 21.37
Momentum Oscillators
RSI (14): 51.41
NEUTRAL
Stoch %K: 36.66
Stoch %D: 29.09
Williams %R: -45.35
Volume & Volatility
BB Upper: $195.48
BB Lower: $150.69
NEUTRAL
OBV: 22,434,968
Vol SMA 20: 640,364
Vol ROC: -5.53%
ATR: $15.06
True Range: $10.77
HV 20: 111.1%
HV 30: 99.8%
HV 60: 97.1%
Data Summary
Data Points: 500
Last Updated: 2026-06-12T21:15:19.623000
Date Range: 2024-06-14T00:00:00 – 2026-06-12T00:00:00
AI Analysis
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
News
Options Activity
- IV Rank (30D)
- 15.95
- IV Rank (7D)
- 100
- Avg IV
- 90.6%
- Straddle (30D)
- $35.65
- Straddle (7D)
- $17.05
- P/C Volume
- 1.79
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Volatility Surface
Enter a ticker to render the implied volatility surface.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
- Beta (1Y vs SPY)
- 3.39
- Correlation (SPY)
- 53.7%
- R²
- 0.29
- Ann. Volatility
- 77.8%
- SPY Volatility
- 12.3%
High volatility - stock moves more than market
Beta & Alpha Over Time
Constituent Performance
Click any bar to view the full quote for that stock.
Constituents
| Symbol | Price | 1 Day | 1 Week | 1 Month |
|---|